Patent · US Expired

Somatostatin agonists

US6025372A · kind A · utility

21Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 1998
Grant dateFeb 15, 2000
Priority date
Expiry dateApr 1, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Somatostatin agonist compounds of formula I are disclosed: ##STR1## including pharmaceutically acceptable salts and hydrates thereof These compounds are useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome and pain. The compounds are potent with high selectivity toward the receptor subtype 2. Pharmaceutical compositions and methods of treatment are also included.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.